Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001940808 | SCV002213972 | likely benign | Methylcobalamin deficiency type cblG | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004042011 | SCV005009584 | uncertain significance | Inborn genetic diseases | 2023-12-14 | criteria provided, single submitter | clinical testing | The c.1855G>C (p.V619L) alteration is located in exon 18 (coding exon 18) of the MTR gene. This alteration results from a G to C substitution at nucleotide position 1855, causing the valine (V) at amino acid position 619 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV004784014 | SCV005396910 | uncertain significance | not provided | 2024-05-02 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |